C

Clinilabs | New Jersey

Research site

(Unclaimed)

Location

4 Industrial Way West 2nd Floor, Eatontown, New Jersey, United States of America

Site insights

Top conditions

Top treatments

PF-06291874

DT-216

LY03005

BPM31510

MK-6552

Dexmedetomidine

Metformin

INZ-701

PF-07261271

MK-6552-003

Parent organization

This site is a part of Clinilabs

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 18 total trials

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

This Phase 2 study (protocol number VLS-01-203) will determine the efficacy, safety, and tolerability of short-term treatment with a VLS-01 transmuco...

Enrolling

Treatment Resistant Depression

Drug: VLS-01-BU Placebo

Drug: VLS-01-203 BU

An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15) (VALOR)

The main purpose of this clinical study is to evaluate a 6-valent OspA-based Lyme disease vaccine (VLA15) for prevention of Lyme disease within North...

Active, not recruiting

Lyme Disease

Biological: VLA15

Other: Saline

ENA-001 for Opioid Induced Respiratory Depression

This study is a Phase I clinical trial to assess the safety, tolerability, and pharmacokinetic (PK) and pharmacodynamic (PD) profiles with single int...

Active, not recruiting

Respiratory Depression

Drug: ENA-001

Drug: Placebo Comparator

Sublingual Dexmedetomidine for Treating Opioid Withdrawal

A major challenge to seeking treatment for opioid use disorder (OUD) is the withdrawal symptoms associated with cessation of opioid use. The signs an...

Active, not recruiting

Opioid Withdrawal

Opioid Use Disorder

Other: Placebo

Drug: BXCL501 (240 micrograms)